Recent News

• 06.11.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.11.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.06.2025 - Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model
• 06.06.2025 - Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model
• 06.04.2025 - Sionna Therapeutics SION-719 & SION-451 Phase 1 Data
• 06.04.2025 - Sionna Therapeutics SION-719 & SION-451 Phase 1 Data
• 06.04.2025 - Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis
• 06.04.2025 - Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis
• 06.03.2025 - Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
• 06.03.2025 - Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Recent Filings